Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Consumer safety group seeks FDA ban of weight loss pill Meridia, citing heart attack risks
Yahoo/AP
Thursday, December 3, 2009 - 11:19am
tags:
Meridia, weight loss, side effects, Abbott Laboratories, Public Citizen
Behind the Business: 3 Questions for Vical
Motley Fool
Thursday, December 3, 2009 - 11:18am
tags:
Vical
Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline
Yahoo
Thursday, December 3, 2009 - 9:59am
tags:
pipelines, Isis Pharmaceuticals
Drug stocks gain; Endo shares retreat
Marketwatch
Thursday, December 3, 2009 - 9:58am
tags:
Endo, drug stocks, Aveed, testosterone
War Stories III: Vermillion -- Up 215,000% -- Plans Escape from Bankruptcy
BNET Pharma
Thursday, December 3, 2009 - 9:57am
tags:
Vermillion, bankruptcy
Fed Probe Into Johnson & Johnson Reaches Zero Hour
Pharmalot
Thursday, December 3, 2009 - 9:51am
tags:
JNJ, Scios, Natrecor
Gilead-Glaxo Deal Targets Asia
Yahoo/Zacks.com
Thursday, December 3, 2009 - 9:45am
tags:
Gilead Sciences, Asia, GSK, partnerships, Viread, Bristol-Myers Squibb
Novartis cleared by EC for a COPD treatment
Marketwatch
Thursday, December 3, 2009 - 9:43am
tags:
COPD, Novartis, Europe
Cephalon sues Teva over sleep drug Nuvigil
Yahoo/AP
Thursday, December 3, 2009 - 8:54am
tags:
Teva Pharmaceuticals, patents, NUVIGIL, generics
Vertex Raising Money -- Again!
TheStreet.com
Thursday, December 3, 2009 - 8:53am
tags:
Vertex Pharmaceuticals, stock offering
Sanofi warning on antidepressant Norpramin
Yahoo/Reuters
Thursday, December 3, 2009 - 8:52am
tags:
antidepressants, Norpramin, warning, Sanofi
AstraZeneca, Targacept to develop depression drug
Marketwatch
Thursday, December 3, 2009 - 8:50am
tags:
AstraZeneca, depression, Targacept
Lilly Urged Zyprexa Use Without Proper Diagnosis
BNET Pharma
Wednesday, December 2, 2009 - 9:31pm
tags:
Eli Lilly, Zyprexa
Biotech cos. rise as gov't OKs new stem cell lines Biotech companies soar as federal government names new stem cell lines for testing
Yahoo/AP
Wednesday, December 2, 2009 - 9:19pm
tags:
StemCells, stem cells, Geron
Roche Makes Strides in Race Against Merck
Minyanville
Wednesday, December 2, 2009 - 3:10pm
tags:
Roche, Merck, diabetes, taspoglutide
Titan Pharmaceutical: More Likely Buyout Target as Patent Protection Is Approved
Seeking Alpha
Wednesday, December 2, 2009 - 2:01pm
tags:
patents, Titan, Novartis
Sanofi Layoffs Are a Lesson in How Not to Do It
BNET Pharma
Wednesday, December 2, 2009 - 2:00pm
tags:
Sanofi, layoffs
Sun gets Taro investor support for buyout
Fierce Pharma
Wednesday, December 2, 2009 - 1:59pm
tags:
Taro, Sun Pharma, M&A
Human Genome to Raise Money
Yahoo/Zacks.com
Wednesday, December 2, 2009 - 1:55pm
tags:
GSK, Human Genome Sciences
Sanofi's Cancer Division Next on the Chopping Block? Up to 1,200 Jobs Gone This Week
BNET Pharma
Wednesday, December 2, 2009 - 10:05am
tags:
layoffs, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.